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ABSTRACT
Conditions have been established for the fractionation of subcellular components of rat
forebrain homogenates by zonal isopycnic equilibration in continuous sucrose density
gradients using a B-XIV rotor . The fractions were analyzed biochemically and by ultra-
structural morphometry . Starting from postnuclear supernates of forebrain homogenates,
it has been possible to resolve three distinct populations of nerve endings from one another,
as well as from free mitochondria and myelin fragments. The three types of nerve endings
differ in their apparent specific gravity, their biochemical properties, and their ability
selectively to accumulate exogenous transmitter substances in vitro . These three particle
populations are likely to represent, in order of increasing modal equilibrium density, (a)
cholinergic nerve endings, characterized by their high content of acetylcholine, (b) y-amino
butyric acid (GABA) -containing nerve endings with high glutamate decarboxylase activity
and the ability to accumulate exogenous GABA, (c) adrenergic nerve endings that accumu-
late exogenous dopamine and noradrenaline and exhibit high monoamine oxidase activity.
INTRODUCTION
Whittaker (1, 2) and de Robertis (3) were the first
to isolate nerve ending particles from brain tissue
homogenates, and to interpret them as detached,
presynaptic boutons sheared off and resealed dur-
ing homogenization of the tissue . Many other
workers have since studied these structures by
morphological and biochemical techniques . Under
the assumption that the biochemical and bio-
physical properties of nerve endings reflect the
functional characteristics of the synaptic region,
and that these properties are largely preserved
during homogenization, one would expect to find
several distinct populations of nerve endings
corresponding to the different systems of neuro-
transmission. Subfractionation of crude mito-
chondrial fractions from brain homogenates of
different species has indeed provided evidence that
nerve endings containing specific transmitters can
be resolved from each other (4-7) . These results
have been obtained mainly by centrifugation
through discontinuous density gradients .
The aim of this work was to define nerve ending
populations which would be suitable for the study
of interactions of psychotropic drugs with synaptic
structures. This paper thus reports an analytical
procedure for the biochemical, morphological, and
functional characterization of nerve endings .
MATERIALS AND METHODS
Fractionation Techniques
Male RAC rats from Tierfarm AG, Sisseln,
Switzerland, kept on a standard diet (Nafag pellets,
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ments. The rats were killed by decapitation and the
brain was quickly removed, freed from blood, and
put into ice-cold 0.32 M sucrose within 2 min after
sacrifice. All subsequent preparation steps were
carried out at 0 °C. The forebrain was dissected from
the cerebellum by a cut behind the superior colliculi,
and homogenized for 1 min at 800 rpm in 9 vol of
0.32 M sucrose. A standard Teflon-glass homogenizer
(Type B, Arthur H. Thomas Co., Philadelphia, Pa.)
with smooth pestle tip was used . The pestle was
driven by a drilling machine, which was moved
automatically up and down, and was set to perform
one full stroke in I min . A nuclear pellet and a post-
nuclear supernate were separated at an average
integrated centrifugal force of 10,000 g-min in an
MSE model 6L refrigerated centrifuge (Measuring
and Scientific Equipment, Ltd ., Crawley, Sussex,
England), using a no. 59560 rotor with adaptors for
30-ml glass tubes . The postnuclear supernate was
fractionated by zonal isopycnic equilibration through
continuous sucrose density gradients in a B-XIV rotor
operated by an MSE SS-65 ultracentrifuge . The
gradients were prepared with two simultaneously
driven syringes of equal cross section and approxi-
mately 200-m1 volume, as described by Leighton
et al. (8), and directly injected into the rotor through
the edge line.
The rotor was filled and emptied at a rate of 20-30
ml/min while rotating at 2,000 rpm. The overlayer,
cushion, and 60% sucrose solution s used to displace
the rotor content at the end of the experiments were
pumped into the rotor by means of a vario Perpex II
peristaltic pump (Guldener, Zürich, Switzerland) .
Various types of gradients were tried in an attempt
to achieve a satisfactory resolution (see Results).
In most of the experiments described in this paper,
the following starting conditions were adopted: 80 ml
of postnuclear supernate in 0.32 M sucrose, corre-
sponding to 2 g of tissue, were sampled on a shallow
400-m1 gradient extending linearly with respect to
volume between the densities 1 .11 and 1 .20, and
overlaid by 70 ml of 0 .25 M sucrose. The gradient
rested on approximately 100 ml of a 60% sucrose
cushion. Centrifugation was carried out at 30,000
rpm for 2.5 h at an average temperature of 8 °C.
Biochemical Analyses
The starting material and the fractions obtained
were assayed for a number of enzyme activities and
for their content of some nonenzymatic constituents.
Photometric measurements were performed in a
Zeiss PM4 spectrophotometer equipped with a
thermostatically controlled automatic cell unit with
six cuvettes (Carl Zeiss, Oberkochen, W. Germany),
and a transmittance-absorbance converter . For time-
'Percent concentrations are always wt/vol .
course determinations, the absorbance as such, or its
logarithm, was recorded on a linear-log W. and W.
recorder, model 3011 (W. and W. Electronic Ltd.,
Basel, Switzerland). Fluorometric assays were meas-
ured in an Hitachi-Perkin-Elmer fluorescence spec-
trometer model 203 (Perkin-Elmer Corp., Electro-
Optical Div., Norwalk, Conn.). Automatic analyses
were performed in a Carlo Erba automatic chemical
analyzer, system 1500 (Carlo Erba, Milan, Italy)
consisting of a sample distributor, model SD3, with
a cooled sample tray, a proportioning pump, a three-
channel flow photometer, model SS27, and Perkin-
Elmer recorders, model 159. Radioactivity was
measured in a Beckman LS-133 scintillation counter
(Beckman Instruments International S .A., Geneva,
Switzerland).
ACETYLCHOLINE : Acetylcholine was estimated
biologically using the dorsal muscle of the leech . A
narrow strip of the muscle was suspended under
tension of 500 mg in a 10-ml Tyrode bath saturated
with 95% 02 plus 5% CO2 at room temperature,
and contraction of the strip was recorded auxo-
tonically by means of a strain gauge transducer. To
each test sample or acetylcholine standard, eserine
(0.1 ug/ml) was added. At this concentration, eserine
optimally increased the sensitivity of the muscle and
completely inhibited acetylcholinesterase. Before
and after each series of determinations, the system
was calibrated with increasing concentrations of
acetylcholine. Within the range of 1-20 ng of ace-
tylcholine, a steep but reproducible logarithmic
dose-response curve was obtained. In fractionation
experiments in which the distribution of particulate
acetylcholine was measured, all the sucrose solutions
used contained 2 X 10-s M eserine in order fully to
inhibit acetylcholinesterase. Fractions from zonal
centrifugations were diluted with twice their volume
of 0.32 M sucrose containing eserine, and the par-
ticulate material pelleted in an angle rotor, MSE
no. 59593, at 3 X 10 6 g-min. The pellets were resus-
pended in Tyrode's solution, adjusted to pH 4 by
the addition of HCI, and heated in a boiling water
bath for 10 min (9). After allowing the samples to
cool to room temperature, the precipitate was re-
moved by centrifugation, and the supernate read-
justed to pH 7.4 with NaOH and diluted with
Tyrode's solution to a concentration suitable for the
assay.
ACETYLCHOLINESTERASE (EC 3 .1 .1 .7)
Acetylcholinesterase was assayed in 60 mM sodium
phosphate buffer, pH 7.4, in the presence of 5 mM
acetylcholine hydrochloride and 0 .01% Triton-X-
100. Incubation was carried out at 37°C for 60 min
and stopped by the addition of an equal volume of
0.4 M perchloric acid. The precipitate was removed
by centrifugation and the supernate was assayed for
acetylcholine according to the method of Hestrin
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467(10). Blanks were obtained by omitting the substrate,
and standards by omitting the sample.
N-ACETYL-U-GLUCOSAMINIDASE (EC
3 .2 .1 .30) : N-Acetyl-ß-glucosaminidase was esti-
mated essentially as described by Peters et al . (11) .
Incubation was carried out at 25°C for 10 min in
50 mM sodium acetate buffer, pH 5.0, containing
1 mM 4-methylumbelliferyl-2-acetamido-2-deoxy-ß-
n-glucopyranoside and 0.1% Triton-X-100. Blanks
were run for each fraction by adding the sample after
the stopping solution . Standard assays contained 50
nmol 4-methylumbelliferone instead of substrate .
ATPASE (Ec 3 .6 .1 .3) : ATPase was measured
in 0. 1 M Tris-acetate buffer, pH 7 .4, in the presence
of 2.2 mM ATP, 2 mM magnesium sulfate, 160 mM
sodium chloride, 15 mM potassium chloride, 3 mM
L-cysteine, and 0.01% Triton-X-100. Incubation was
carried out at 37 °C for 20 min and stopped by the
addition of 2 vol of a solution containing 15% tri-
chloroacetic acid, 3% ascorbic acid, and 0.5%
EDTA. The precipitate was removed by filtration
through Whatman GF/C filters, and the released
inorganic phosphate determined according to Bag-
insky et al. (12). Blanks were run for each fraction
by adding the substrate after the stopping solution .
Standard assays contained 0.1 i .mol potassium phos-
phate.
CATALASE (EC 1 .11 .1 .6) : Catalase was de-
d termined as described by Baudhuin et al . (13):
Maximum activity was obtained by preincubating
the samples at 0 °C for 2 h in a solution containing
1 mM sodium bicarbonate, 1 mM EDTA, 0.001%'
Triton-X-100, and 0.1% ethanol adjusted to pH 7.4
with HCl. The assay mixture consisted of 18 mM
imidazole-HC1 buffer, pH 7.0, 1 mg/ml of bovine
serum albumin (BSA), and 2.67 mM H202. Incuba-
tion was performed at 0°C for 30 min and stopped
by the addition of 3 vol of 7 mM titanium sulfate-
oxysulfate in 2 N sulfuric acid . After removal of the
precipitate by filtration (Whatman GF/C), absorb-
ance was measured at 405 nm.
CHOLESTEROL : Cholesterol was extracted in 20
vol of chloroform/methanol (2 :1). The organic phase
was washed twice with 2 .5 vol of distilled water in
order to eliminate traces of sucrose, and cholesterol
determined fluorometrically according to Solow et al .
(14). Cholesterol solutions in chloroform-methanol
were used as standards and treated in the same way
as the extracts.
CYTOCHROME OXIDASE (EC 1 .9.3 .1) : Max-
imum activity of cytochrome oxidase was obtained
by preincubating the samples at 0 °C for 1 h in the
presence of 33 mM potassium phosphate buffer, pH
7.4, 1 mM EDTA, and 0.1 % Emasol 4130 (15). The
assay was carried out at 25°C in 1-ml cuvettes using
the above medium to which 31 mM 90%-reduced
cytochrome c was added. The rate of cytochrome c
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oxidation, which obeys first-order kinetics, was re-
corded linearly at 550 nm on a linear-log recorder
with the help of a transmittance-absorbance con-
verter (see above), according to the principle de-
scribed by Leighton et al . (8).
GLUTAMATE DECARBOXYLASE (EC
4 .1 .1 .15) : Glutamate decarboxylase was meas-
ured by determining the amount of 14C02 liberated
from [1-14C]glutamic acid as described by Fonnum
(16) . Incubation was carried out at 37 °C for 60 min
in the presence of 2 µCi of DL-[l -14C]glutamic acid
(10 mCi per mmol), 25 MM L-glutamic acid, 0.1 mM
pyridoxal phosphate, 0.1 M sodium phosphate
buffer, pH 6.2, and 0.05% Triton-X-100, using the
technique described by Baggiolini and Bickel (17).
The reaction was stopped by the addition of HC1 to a
concentration of 0.1 N and incubation was continued
for another 30 min in order to ensure complete re-
covery of 14C02. The samples were counted after
addition of 10 ml of 0 .6% of PBD-scintillator (see
Materials), in toluene.
GLUTAMATE DEHYDROGENASE (EC 1 .4 .1 .3) :
Glutamate dehydrogenase was assayed as described
by Beaufay et al. (18), with the following modifica-
tions : Glycylglycine, 20 mM, pH 7 .7, was used as
the buffer, nicotinamide and cyanide were omitted,
and the substrate concentration was 0 .8 mM. Incuba-
tion- was carried out at 25°C in 1-ml Cuvettes. The
reaction was started by the addition of the substrate
after a 3-min preincubation which was found neces-
g,ary to overcome the initial lag phase of the reaction .
LACTIC DEHYDROGENASE (EC 1 .1 .1 .27) : Lac-
tic:-dehydrogenase was assayed at 25 °C in 1-ml cu-
vettes using a medium which contained 50 mM
sodium phosphate buffer, pH 7.5, 90 µM NADH,
0.44 mM sodium pyruvate, and 0.01 % Triton-X-100.
The reaction was started by the addition of substrate
after 1 min of preincubation, and the decrease in
absorbance at 340 nm was recorded. Blanks were
run without substrate .
MONOAMINE OXIDASE (EC 1 .4 .3 .4) : Mono-
amine oxidase was determined according to Krajl
(19) . Incubation was carried out at 37°C for 20 min
in 33 mM Tris-HC1 buffer, pH 8.5, 51 µM kynur-
amine hydrobromide, and 0.01% Triton-X-100.
Standard assays contained 3 .3 nmol 4-hydroxy-
quinoline. Blanks were run for each fraction by
adding the substrate after the stopping solution .
a-NAPHTHYLACETATE ESTERASE (EC
3 .1 .1 .6) : a-Naphthylacetate esterase was deter-
mined automatically. The liberated a-naphthol was
measured photometrically after coupling with fast
red. Sample (0.45 ml/min) and a-naphthylacetate,
0.75 mM in 50 mM sodium citrate buffer, pH 5.8
(1 .88 ml/min), were incubated at 37 °C for 15 min.
Fast red ITR salt, 0.2% in 0.2 M sodium acetate
buffer, pH 4.5, containing 1 % of Brij (1 .36 ml/min),was then added, and the reaction allowed to proceed
at 37°C for 10 min before the mixture entered the
flow photometer. Transmittance at 550 nm was
recorded on log paper. 20 samples were processed
per hour with a 1 :2 sampling-to-washing ratio. A
standard solution containing 0.1 mM ce-naphthol in
20 mM NaOH was used .
5'-NUCLEOTIDASE (EC 3 .1 .3 .5) : 5'-Nucleo-
tidase was assayed in 50 mM Tris-HCl buffer, pH
7.7, in the presence of 3 mM AMP, 2 mM magnesium
sulfate, and 0.1% Triton-X-100. Incubation was
carried out at 37 °C for 60 min and stopped by the
addition of 3 vol of a solution containing 15% tri-
chloroacetic acid, 3% ascorbic acid, and 0.5%
EDTA. Inorganic phosphate was determined as
described for ATPase.
PROTEIN : Protein was determined as described
by Leighton et al. (8). BSA was used as a standard .
Uptake Studies
The uptake of labeled dopamine, noradrenaline,
serotonin, and y-amino-butyric acid by subcellular
particles was studied at 25 °C with postnuclear
supernates in a modified Krebs-Ringer solution (20) .
1 vol of postnuclear supernate obtained from a 10%
homogenate was diluted with 3 vol of the medium,
preincubated at 25°C for 10 min, and then supple-
mented with the labeled compound in different
concentrations. Uptake was terminated at different
time intervals by cooling the reaction mixture in an
ice bath. The particulate material was then sedi-
mented at 3 X 106 g-min, rinsed twice with small
amounts of isotonic saline, extracted by homogeniza-
tion in ethanol, and freed from precipitated protein
by centrifugation at 10,000 g-min. When the sub-
cellular distribution of the labeled compound was
investigated, the 3 X 10 6 g-min pellets were rinsed
with 0.32 M sucrose, resuspended in the same solu-
tion, and fractionated as described above. Radio-
activity was measured in 0.1-m samples of the
ethanol or aqueous fractions after addition of 10 ml
of 12% ethanolamine in methanol and 10 ml of 0.6%
PBD in toluene. The results are expressed as the
particulate-to-medium ratios V/S, where V is the
transmitter uptake in millimoles per gram of pellet
wet weight (3 X 106 g-min), and S is the initial
medium concentration of transmitter in millimoles
per milliliter.
Morphological Techniques
The samples were prepared according to the proce-
dure introduced by Baudhuin et al. (21) . The frac-
tions were diluted to approximately 0.5 mg/ml of
protein, and 0.1 ml portions were mixed with 19 vol
of ice-cold 0.1 M cacodylate buffer, pH 7 .4, con-
taining 1 .5% glutaraldehyde, and adjusted to a
tonicity of 340 mosmol by the addition of sucrose .
The suspension was filtered through Millipore filter
membranes with pore size 0.025 tm (VSWP filters,
Millipore AG, Kloten, Switzerland) under nitrogen
pressure of 1-2 atm. Filtration time was 20-30 min.
The particle pellicle was covered with a second filter
of the same type and carried through the subsequent
preparation steps. Refixation was performed for 2 h
in 1 % osmium tetroxide buffered with 50 mM sodium
phosphate made isotonic with sucrose . The filters
were dehydrated in graded alcohol solutions and
released into propylene oxide where the membranes
were dissolved within 10-12 hours . The pellicle was
embedded in Epon (22), and grey sections were cut
at right-angles to the pellicle surface . After staining
with uranyl acetate and lead citrate (23) the speci-
mens were examined with a Siemens Elmiskop 101 .
The volume densities of nerve endings, and of free
and intraterminal mitochondria were determined
according to the principles outlined by Weibel (24).
Materials
All solutions were made up in glass-distilled water.
Special attention was devoted to the sucrose solutions
used for the homogenization of the tissue and for
preparing the density gradients . Sucrose "for density
gradient centrifugation" (E. Merck A.G., Darmstadt,
W. Germany) was used, and the water was freed of
carbon dioxide by boiling just before use. Reagents
used in the present work were obtained from the
following sources : Fluka A.G., Basel, Switzerland,
osmium tetraacetic acid, and 2-(4-tertiary butyl-
phenyl)-5-(4-biphenyl)-1,3,4-oxadiazole (PBD) ;
KAO Atlas Ltd., Tokyo, Japan, Emasol 4130 ; Koch-
Light Laboratories, Ltd ., Colnbrook, Bucks., England,
4-methylumbelliferyl-2-acetamido-2- deoxy-ß-D-glu-
copyranoside, and 4-methylumbelliferone ; E. Merck
A.G., Darmstadt, W. Germany, eserine; Packard
Instrument Co., Inc., Downers Grove, Illinois,
Triton-X-100; Schuchardt Ltd., Munich, W. Ger-
many, titanium sulfate-titanium oxysulfate, and
cholesterol ; Siegfried Ltd., Zofingen, Switzerland,
ethylenediamine tetraacetic acid (EDTA, disodium
salt) ; Sigma Chemical Co., St. Louis, Mo., AMP,
ATP, cytochrome c (type III from horse heart), fast
red ITR salt, 4-hydroxiquinoline, kynuramine
dihydrobromide, and NADH ; TAAB Laboratories,
Reading, Sussex, England, glutaraldehyde ; Tech-
nicon Instruments Corp ., Tarrytown, N. Y., Brij-35 ;
Wander Ltd., Berne, Switzerland, acetylcholine
hydrochloride, Lamisil . The following labeled com-
pounds were obtained from New England Nuclear,
Boston, Mass., y-amino-[2,3 3H]butyric acid, [3,4-
3H]dihydroxyphenylethylamine, DL[1-14C]glutamic
acid, [5-3H]hydroxytryptamine, and DL[7-14C]nor-
epinephrine, D-bitartrate.
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469TABLE I
Relative Content of Constituents of Rat Forebrain Homogenates in the Postnuclear
Supernate E Used as the Starting Material for the Fractionation Experiments *
* Mean values. Standard deviation is given if more than three determinations
were performed.
$ Because of lack of space in the incubation apparatus (17), the distribution
of GAD between postnuclear supernate (E) and nuclear pellet was deter-
mined only twice.
TABLE II
Enzymes and Other Constituents Measured. Specific Activities and Contents in the Starting
Material, and Average Percent Recoveries upon Fractionation .
Average percent
Specific activity*
	
recovery upon
mU/mg protein
	
fractionation
	
Number of
Constituent
	
(mean t SD)
	
(mean f SD)
	
experiments
* The unit of cytochrome oxidase activity is defined by Cooperstein and Lazarow
(40), and that of catalase by Leighton et al. (8). For all other enzymes tested, one unit
of activity corresponds to the amount of enzyme which degrades 1 mol of substrate
per min.
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Cytochrome oxidase 64 .6 f 22 .4 100 .9 f 23 .0 15
Glutamate dehydrogenase 86 .3 f 14 .6 86 .6 f 10 .0 17
Monoamine oxidase 1 .91 f 0 .26 88 .9 f 9 .2 18
Glutamate decarboxylase 8 .30 f 0 .31 76 .6 t 8 .3 10
a-Naphtylacetate esterase 67 .7 f 14 .9 88 .1 f 14 .9 14
Na+/K+ + Mg++ - ATPase 266 .0 f 60 89 .4 t 15 .9 15
5'-Nucleotidase 22.9 t 2 .4 96.5 f 11 .9 4
Acetylcholinesterase 113 .6 51 .0 1
Lactic dehydrogenase 653 .0 t 60 114.8 f 17 .5 15
N-acetyl-(0-glucosaminidase 1 .24 t 0 .2 90.8 f 9 .8 10
Catalase 1 .13 93 .0 2
Acetylcholine (µg/g of brain) 0.52 t 0.36 104 .6 t 23 .0 3
Cholesterol (mg/g of brain) 4.92 88.1 1
Constituent
Percent of total
activity recovered
in E Recovery
Number of
experiments
Protein 80 .9 f 8 .9 106 .3 t 11 .5 17
Cytochrome oxidase 89 .8 f 3 .6 95 .9 t 10.3 17
Glutamate dehydrogenase 84 .9 f 5 .5 95.1 f 16.3 14
Monoamine oxidase 78.5 t 5.3 104 .3 f 9.5 16
Glutamate decarboxylase$ 98 .0 97 .3 2
a-Naphthylacetate esterase 81 .7 f 9 .5 104 .4 t 9.6 17
Na+/K+ + Mg++ - ATPase 74 .0 f 12 .5 107 .2 t 16.7 8
5'-Nucleotidase 82 .8 98 .5 3
Acetylcholinesterase 90 .4 105 .5 1
Lactic dehydrogenase 91 .1 f 4 .0 102 .7 f 14 .9 11
N-acetyl-ß-glucosaminidase 83 .1 f 9 .3 106 .1 t 12.8 7
Catalase 79 .9 95 .1 2
Cholesterol 72 .4 106 .8 2RESULTS
Starting Material
The homogenization of the brain and the
preparation of the postnuclear supernate that was
used as the starting material yielded very repro-
ducible results. Cell disruption was highly effective
as judged by the presence of more than 90% of the
total activity of some of the enzymes in the super-
Date fraction (see Table I). The specific activities
of the enzymes and the concentrations of non-
enzymic constituents in the starting material of
the fractionation experiments are given in Table
II. This table also shows the average recoveries for
these constituents upon fractionation.
Fractionation Experiments
The fractionation data presented in this section
were all obtained in the shallow, large-volume
density gradient described under Materials and
Methods. Data obtained under different conditions
will be briefly commented upon in a subsequent
section.
Figs. 1 and 2 show the results of 2 out of 17
such experiments . In describing these data, it is
useful to begin with the distribution profiles of
cytochrome oxidase and of glutamate dehydro-
genase (GDH), which enable us to identify the
equilibrium position of the mitochondria (25) .
The two profiles, although not identical, have a
similar shape, and essentially the same modal
equilibrium density of 1 .182 f 0.003, and 1 .183 -+-
0.006, respectively (see Table III). The main
cytochrome oxidase peak is frequently accom-
panied by a minor shoulder or peak in the middle
of the gradient where very little GDH activity is
found (see Figs. 2 and 3) . Monoamine oxidase
(MAO), which is known to be associated with the
outer membrane of rat liver mitochondria (26),
and which is generally considered to be a mito-
chondrial marker in nervous tissue as well (27, 28),
shows a density equilibration profile that differs
considerably from that of the two former enzymes .
MAO exhibits in most of the experiments a broad
peak with modal density of 1.169 f 0.004. In
some experiments, the MAO band is resolved into
two strongly overlapping peaks, one coinciding
with, the other adjacent to, the peaks of cyto-
chrome oxidase and GDH. The dissociation of
MAO and cytochrome oxidase is further docu-
mented in Fig. 3 which shows the distributions of
both enzymes in eight different experiments .
Cytochrome oxidase
50
	
50
Percent of volume
FIGURE 1 Isopycnic equilibration of subeellular com-
ponents of a postnuclear supernate of rat forebrain
homogenate. Graphs are normalized distribution histo-
grams as a function of the volume collected . Ordinate
is concentration in fraction relative to concentration
corresponding to uniform distribution throughout the
gradient. The upper left-hand graph shows the average
density of each fraction. Percentage recoveries were
100 for protein, 118 for lactic dehydrogenase, 105 for
a-naphthylacetate esterase, 120 for Na+/+- Mg++-
ATPase, 89 for cytochrome oxidase, 98 for glutamate
dehydrogenase, 98 for monoamine oxidase, 117 for
glutamate decarboxylase, 103 for particulate acetyl-
choline, and 94 for N-acetyl-ß-glucosaminidase.
Despite a rather high variability of the MAO
profiles, these data indicate the presence of two
MAO-containing particle populations with differ-
ent mean equilibrium densities. A minor portion
of the total MAO activity is always found at the
border between the starting zone and the gradient,
at a density of approximately 1 .100. In this zone,
-6
-4
-2
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FIGURE 2 Isopycnic equilibration of subcellular
components of a postnuclear supernate of rat fore-
brain homogenate. The data are calculated and pre-
sented exactly as in Fig. 1. Percentage recoveries were
108 for protein, 1Q4 for lactic dehydrogenase, 77 for
a-naphthylacetate esterase, 125 for catalase, 67 for
cytochrome oxidase, 83 for glutamate dehydrogenase,
87 for monoamine oxidase, 89 for glutamate decar-
boxylase, 100 for 5'-nucleotidase, and 92 for N-acetyl-ß-
glucosaminidase.
we find very high activities of the sodium-potas-
sium-activated, magnesium-dependent ATPase,
5'-nucleotidase, and a-naphthylacetate esterase .
These enzymes all exhibit a second much lower
and broader peak in the middle of the gradient .
In two experiments, the subcellular distribution
of cholesterol was found to be almost identical
with that of the 5'-nucleotidase activity. These
data suggest that the material which accumulates
at the border between the starting zone and the
gradient represents mostly fragments of the myelin
Cytochrome oxidase
50
	
50
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* Standard deviations were calculated only if
more than three single values were available .
Minor peaks accounting for less than 10% of the
total, and peaks extending into the sample zone
were disregarded.
$ In 4 out of 18 fractionations MAO showed 2
peaks with modal densities 1 .181 f 0.002, and
1 .166 f 0.008, respectively.
and of the plasma membranes . The minor portion
of MAO activity in this zone could indicate the
presence of mitochondrial outer membrane frag-
ments. However, other, nonmembrane-bound
enzymes, e.g. catalase and N-acetyl-ß-glucosamini-
dase, are also enriched in this zone . They may
belong to particles too small to pass the density
step under the adopted experimental conditions,
or may be localized in fragments of myelinated
axons.
Because of the association of glutamate decar-
boxylase (GAD) (16, 29) and particulate acetyl-
choline (5, 30) with nerve endings, we have deter-
mined their density distributions in a number of
TABLE III
-6
Average Modal Densities of Enzymes
and Other Constituents -4
- 2
Average modal
density*
(mean do SD) Constituent
-4 1 .101 f 0.010 a-Naphthylacetate esterase
1 .104 f 0.003 ATPase
-2 1 .104 5'-Nucleotidase ; acetylcholin-
1 .105
esterase
Cholesterol
-3 1 .137 t 0.003 Acetylcholine
-2
1
c 1 .148 5'-Nucleotidase ; acetylcholin-
m esterase
d 1 .149 ± 0.004 Glutamate decarboxylase
3 , 1 . 150 t 0.003 ATPase; a-naphthylacetate es-
0
2 terase
-1
41
1 .150 f 0.006 Lactic dehydrogenase
1 .150 Catalase
6 1 .156 t 0 .005 N-acetyl-,(3-glucosaminidase
1 .156 Cholesterol
4
1 .169 f 0 .007 Monoamine oxidase$
-2
1 .182 f 0 .003 Cytochrome oxidase
1 .183 f 0 .005 Glutamate dehydrogenase
-1 1 .199 f 0 .008 N-acetyl-(3-glucosaminidase
Glutamate dehydrogenase
2
Lactic dehydrogenase
Monoamine oxidase
4-
C 2- 1
m Glutamate decarboxylase
C
c
0
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2FIGURE 3 Distribution of cytochrome oxidase (white
histograms) and monoamine oxidase activity (shaded
histograms) in eight isopycnic equilibration experi-
ments with rat forebrain homogenate . The data are
presented exactly as in Fig. 1. Percentage recoveries
(•SD) were 91 t 25 for cytochrome oxidase and 102 f
7 for monoamine oxidase.
experiments. About half of the GAD activity of
each preparation equilibrates in a relatively sharp,
symmetrical peak with average modal density of
1 .149 • 0.004 and is well resolved from the
MAO activity profile . The remainder of the GAD
is retained in the starting zone, together with the
soluble proteins. This bimodal distribution could
result from the partial release of enzyme from
nerve endings during homogenization, as sug-
gested by Salganikoff et al. (29). These authors
found no soluble GAD after homogenization in
the presence of calcium, and concluded that
calcium prevents nerve ending damage and con-
sequently GAD release . However, Fonnum showed
that upon addition of calcium, soluble GAD binds
strongly to sedimentable material (16) . It seems
likely, therefore, that the GAD found in the
starting zone represents enzyme originally pres-
ent in the cytosol of neuronal bodies and/or
glial cells. The particulate acetylcholine equili-
brates in a narrow band with modal density of
1 .137 t 0.003 which is slightly but clearly dis-
sociated from the heavy peak of GAD . This indi-
cates that the nerve endings containing GAD and
the cholinergic nerve endings, which we recognize
by their acetylcholine content, are distinct entities,
and differ sufficiently in their physical properties
to be resolved in a sucrose density gradient .
As expected, lactic dehydrogenase (LDH) is
mostly retained in the starting zone . A consistent
portion of its activity, however, is distributed
throughout the gradient and possibly shows a
relative enrichment in the middle of the gradient .
In a number of experiments, the distributions of
N-acetyl-3-glucosaminidase and catalase, which
were selected as lysosomal and peroxisomal
markers, respectively, were also determined . N-
acetyl-/3-glucosaminidase activity is found through-
out the gradient. Its distribution profile is charac-
terized by two highly reproducible peaks, one
with approximately the same modal density as
the light peak of the 5'-nucleotidase (and other
membrane markers measured), and the other
with a modal density of 1 .199 f 0.008. The
first-mentioned peak extends over the sample zone
into the beginning of the gradient, as does the
corresponding peak of protein. Its activity is pre-
sumably due to N-acetyl-$-glucosaminidase re-
leased from damaged lysosomes, as well as enzyme
bound to structures retained within the membrane
zone. The distribution of N-acetyl-/3-glucosamini-
dase activity in the gradient supports the notion
that brain lysosomes are very heterogeneous.
Catalase exhibits a less complex distribution.
About one-third of its activity is retained near
the starting zone, together with a similar fraction
of the N-acetyl-/3-glucosaminidase activity (see
above). The remainder is found in a broad, sym-
metrical peak which clearly indicates that most of
the enzyme is particle bound. Catalase could be
confined to discrete particles or be present in
soluble form in the cytosol of nerve endings which
are the main particulate component of the median
zones of the gradient. The obtained distribution
profiles argue in favor of the first possibility . In
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473fact, if catalase were soluble as is LDH, a much
larger fraction of its activity would remain in the
sample zone. The protein distribution is charac-
terized by two peaks, each accounting for approx-
imately half of the total content . The first peak
covers the sample zone and the beginning of the
gradient, while the second, much broader peak
has a modal density of 1 .150. The highest relative
protein contents are always found at the beginning
of the gradient together with high activities of
the membrane enzymes. In the outer half of the
gradient, the protein content decreases steadily
with increasing equilibrium density. Very little
protein is found together with the highest activity
of cytochrome oxidase.
Fractionations in Different Types of
Gradients
The experimental conditions of the fractiona-
tions described above were adopted on the basis
of the results obtained with various types of density
gradients. Although none of these systems showed
any apparent advantage over the one that was
finally used, the results obtained will be briefly
described. Steep sucrose gradients extending
linearly between the density of the sample (1 .04)
and 1 .20 g/ml were used initially . The density
distribution patterns and the average modal den-
sities of most of the constituents were consistent
with those presented in the former section. The
resolution, however, was poor. A significant im-
provement was achieved by the introduction of a
steep density increment from 1 .04 to 1 .10 between
sample zone and gradient. In this system, myelin
and other membranous material could be trapped
at the boundary between the sample zone and the
gradient, thus leaving a large portion of the
equilibration field for heavier particles. We also
used Ficoll density gradients (Pharmacia, Uppsala,
Sweden) in isotonic sucrose but found it of little
advantage. Because of the high viscosity of the
gradient material, centrifugation time had to be
exceedingly long to allow for particle equilibra-
tion. Incomplete equilibration in such gradients
resulted in poor resolution of nerve ending popu-
lations.
Morphological Results
Because of the heterogeneity of the starting
material and the high degree of variability in size
of some of the subcellular structures, the frac-
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tionated material was processed for electron
microscopy under conditions that allowed a mor-
phometrical evaluation of the main structures
present (see Materials and Methods) . Figs. 4-7
are micrographs of the fractions that were analyzed
by morphometry. They were selected from one
fractionation experiment on the basis of the bio-
chemical data. They exhibit, in this order, the
highest relative activities of cytochrome oxidase
(density 1 .185), MAO (1 .165), GAD (1 .155), and
the highest content of particulate acetylcholine
(1 .137) . The results of the morphometrical analy-
sis of micrographs providing three to six complete
surveys of the pellicle depth are presented in
Table IV.
Fig. 4 has a very homogeneous appearance . In
accordance with its high cytochrome oxidase ac-
tivity, it consists almost exclusively of free mito-
chondria which occupy 74% of the total volume
of the structures present. Figs. 5-7 differ strik-
ingly from the mitochondrial fraction but are
similar to each other. The main components are
profiles of nerve endings of different size and
shape. In the MAO-rich fraction (Fig. 5), nerve
endings account for 58% while free mitochondria
occupy only 12% of the total particle volume .
Nerve endings make up 40 % of the particle volume
in the fraction with the highest GAD content and
56% in the peak fraction of particulate acetyl-
choline content (Figs. 6 and 7). In the micro-
graphs of these two last fractions, a number of
membrane profiles of various shapes are noted .
Myelin membranes, however, seem to be totally
absent. A large proportion of the nerve ending
volume is accounted for by intraterminal mito-
chondria . They occupy 22, 23, and 18 % of the
nerve ending volumes in the fractions represented
by Figs. 5, 6, and 7, respectively.
Characterization of Nerve Endings by
Transmitter Uptake
The properties of the nerve endings were further
investigated by assessing their ability to take up
exogenous transmitter substances . Postnuclear
supernates were incubated in the presence of
radioactively labeled dopamine (DA), y-amino
butyric acid (GABA), serotonin (5-HT), or nor-
adrenaline (NA), and the amount of accumulated
radioactivity was determined. The particulate
fraction obtained was resuspended in sucrose and
fractionated by density equilibration. The par-
ticulate-to-medium ratios, which are a measureof transmitter uptake (see Methods), are shown
in Table V.
Fig. 8 shows the density distribution of exoge-
nous DA, NA, GABA, and 5-HT accumulated by
particles of the postnuclear supernate . The dis-
tribution histograms of protein and cytochrome
oxidase are given as references. It should be noted
that in this type of experiment the protein distribu-
tions are not comparable with those obtained using
the standard centrifugation procedure (Figs. I-3) .
This is due to the fact that the particulate material
of the postnuclear supernate is washed in sucrose
(see Materials and Methods) before isopycnic
fractionation, and therefore most of the soluble
protein is removed .
The profiles of transmitter radioactivity are
bimodal in all cases. The first peak is found in the
starting zone and is likely to represent transmitter
which has not been taken up or which has been
released during processing of the starting material .
The second peak is found together with the par-
ticulate material. Its modal density varies accord-
ing to the transmitter used. The peaks of particle-
bound DA and NA are nearly identical. They are
found together with the light half of the MAO
activity and exhibit a modal density of 1 .164. The
peak of particle-bound GABA (modal density
1 .148) coincides with the peak of particulate GAD
activity. Finally, particle-bound 5-HT, which
has a modal density of 1 .143, is well resolved from
the zone of the other two amines, DA and NA, and
does not seem to correspond to any of the bio-
chemical constituents measured.
DISCUSSION
Work from a number of laboratories indicates the
presence in brain homogenates of distinct types of
nerve endings. Cholinergic nerve endings have
been partially resolved from noncholinergic end-
ings in rat brain homogenates (4), and from 5-HT-
containing nerve endings in guinea pig brain
homogenates (5). Furthermore, GABA-containing
nerve endings could be dissociated from adrenergic
(6) and from serotonergic nerve endings (7) by
density gradient centrifugation of brain homoge-
nates from various species .
In the present study, the fractionation of sub-
cellular structures from rat brain homogenates has
been attempted under conditions which differ in
many respects from those of the above investiga-
tions. By omitting the customary prefractionation
by differential centrifugation, we have avoided
an arbitrary selection of structures present in the
homogenate, and also possible artifacts resulting
from damage and aggregation of particles. A very
dilute postnuclear supernate from rat forebrain
homogenate was used as the starting material,
and subjected to zonal isopycnic centrifugation
through a large-volume, shallow sucrose density
gradient in a B-XIV rotor. The maximum angular
velocity was limited to 30,000 rpm in order to
avoid particle damage through hydrostatic pres-
sure (31) . Particulate acetylcholine, glutamate de-
carboxylase (GAD) activity, and accumulation of
exogenous transmitters by selective uptake were
adopted as markers for identifying nerve endings.
Fractions from the density gradients characterized
by these markers were further analyzed by means
of ultrastructural morphometry.
Using this approach, we were able to identify
three distinct populations of nerve endings : (a)
those containing acetylcholine (cholinergic nerve
endings) at a modal equilibrium density of 1 .137 ;
(b) nerve endings with high GAD activity and
the ability to accumulate exogenous GABA, equili-
brating at an average density of 1 .149; (c) adrener-
gic endings characterized by high affinity uptake of
exogenous NA and DA at an average density of
1 .165. Free mitochondria have a modal equilib-
rium density of 1 .182, and are therefore well re-
solved from nerve endings . In the interest of clarity,
the discussion will be focused on the three nerve
ending populations mentioned above.
Cholinergic Nerve Endings
The equilibration profile of particulate acetyl-
choline has a shape that clearly distinguishes it
from all other profiles obtained, including that of
acetylcholinesterase activity. The distribution of
this enzyme determined in a few experiments
either as acetylcholine splitting activity, or as the
eserine-sensitive hydrolysis of a-naphthylacetate,
was indistinguishable from that of the a-naphthyl-
acetate esterase activity. This supports the inter-
pretation of Whittaker (9) that presynaptic ace-
tylcholinesterase activity is low. High relative
concentrations of acetylcholine coincide with com-
paratively low values of protein and very low rela-
tive activities of both cytochrome oxidase and
GDH which are markers for the intraterminal
mitochondria present. This seems to indicate that,
in our starting material, cholinergic endings repre-
sent a small particle population .
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475FIGURES 4-7 Survey electron micrographs of fractions separated by isopycnic equilibration as shown
in Figs. 1 and 2. See descriptions in the text. X 30,000.
FIGURE 4 Fraction with highest relative activity of cytochrome oxidase and GDH (d = 1.183).
FIGURE 5 Fraction with high relative activity of MAO (d = 1.165) coinciding with highest concen-
trations of accumulated DA and NA as determined in other experiments .
476FIGURE 6 Fraction with highest relative activity of GAD (d = 1.155), corresponding to highest con-
centration of accumulated GABA as determined in other experiments .
FIGURE 7 Fraction with highest relative concentration of particulate acetylcholine (d = 1.137).
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477TABLE IV
Relative Volume Densities of Nerve Endings and
Mitochondria in the Fractions Represented by
Figs. 4-7
line (par-
ticulate)
In the first three columns, the relative volume
densities of nerve endings (Vv..), and of free and
intraterminal mitochondria (Vvml and VV ;) are
given with respect to the volume density of all
particles present (VVT ). The last column shows
the relative volume density of intraterminal mito-
chondria with respect to the volume density of
nerve endings.
TABLE V
High-Affinity Uptake of Dopamine, Noradrenaline,
GABA, and Serotonin by Particles of Postnuclear
Supernates of Rat Forebrain Homogenates
* V = mmoles of compound per gram of particulate
material (3 X 106g-min pellet of reaction mixture) ;
S = initial concentration of compound in the
medium (mmoles per milliliter) . The incubation
time required to reach maximal ratios was 15 min
for the amines and 30 min for GABA.
GABA-Containing Nerve Endings
We have identified a second population of nerve
endings, on the basis of the density distribution of
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FIGURE 8 Isopycnic equilibration of dopamine, nor-
adrenaline, GABA, and serotonin (shaded histograms)
after high affinity uptake by particles of postnuclear
supernates of rat forebrain homogenate . The distribu-
tion profile of protein (left-hand graphs) and cyto-
chrome oxidase (right-hand graphs) from the cor-
responding experiments are given as a reference (white
histograms). The data are calculated and presented as
in Fig. 1 . Percentage recoveries were 101 for dopamine,
116 for noradrenaline, 119 for GABA, and 112 for
serotonin.
GAD activity, which differs from that of particu-
late acetylcholine . In postnuclear supernates, these
particles appear to have the property of selective
accumulation of exogenous GABA. Particle-bound
GAD activity and the accumulated GABA show
very similar peaks. This confirms the data of Neal
and Iversen (32) which suggest that GAD, and
both exogenous and endogenous GABA, are local-
ized in the same particle .
Compound
Concentration
in medium
Particulate-to-
medium ratio:
V/S'
(mean f SD)
Number
of
experi-
ments
M
Dopamine 1 X 10-7 26 .1 f 1 .6 3
Noradrenaline 5 X 10-1 5 .2 f 0.5 3
GABA 1 X 10-1 12 .3 f 1 .1 4
Serotonin 1 X 10-1 17 .1 f 0.6 3
Fraction
D
Characteristic
Constituent Density
g/mt
Cytochrome
oxidase
GDH 1 .183 0 .08 0.71 -
MAO 1 .165 0.59 0.12 0 .13 0 .22
GAD 1 .155 0.40 0.02 0.14 0.37
Acetylcho- 1 .137 0 .56 <0.01 0.11 0.18The median zones of the gradient are further
characterized by high relative concentrations of
protein and of the majority of the enzyme activities
measured. In particular, the membrane markers
ATPase, a-naphthylacetate esterase, 5'-nucleoti-
dase, and cholesterol exhibit peaks that closely re-
semble that of particulate GAD. Furthermore, the
cytochrome oxidase profiles frequently show a
minor shoulder (or peak) accompanying GAD,
which is likely to reflect activity from the numerous
intraterminal mitochondria. When free mitochon-
dria and plasma membrane fragments are virtually
absent, these enzyme activities are best attributed
to nerve endings. This indicates that a large por-
tion of these particles equilibrate in the GAD
zones. As it seems unlikely that such great numbers
of nerve endings originate from GABA neurons,
these results suggest that other kinds of nerve end-
ings, having similar physical properties to those
containing GABA, may equilibrate in these zones
but remain unrecognized because of the lack of
specific biochemical markers. There are indeed in-
dications that this may be the case . Uptake studies
have shown that particles which accumulate 5-HT
have a similar density distribution to those accu-
mulating GABA. The 5-HT particles could well
represent a distinct type of nerve ending which
cannot be further characterized by the present
selection of biochemical markers .
Adrenergic Nerve Endings
Adrenergic endings have been identified in this
work as the particles that accumulate both NA and
DA. They represent the nerve ending population
with the highest equilibrium density, and can be
resolved from the GABA- and 5-HT-accumulating
particles, as well as from free mitochondria. The
equilibration profiles of accumulated NA and DA
cover the light half of the MAO profiles. It is re-
markable that the peaks of the amine contents co-
incide with highest relative activities of MAO,
while the profiles of all other enzyme activites
measured show a generally pronounced diminu-
tion in this zone. It is therefore tempting to assume
that high specific activity of MAO may be a char-
acteristic property of adrenergic nerve endings.
The relative activity of MAO is about equal in
the equilibration zone of free mitochondria and
in the peak zone of adrenergic endings . In the
latter, cytochrome oxidase activity is compara-
tively low and free mitochondria account for only
slightly more than 10/0 of the particle volume. The
difference between the MAO and cytochrome oxi-
dise distributions suggests the presence of an
MAO-containing particle population distinct from
the bulk of the free mitochondria. There is no indi-
cation that this may represent a subpopulation of
free mitochondria. Differences between neuronal
and glial mitochondria have been described in
rabbit and bovine brain by Hamberger et al . (33).
Both types of mitochondria, however, equilibrate
at much higher densities than that of the light
MAO zones and exhibit similar MAO : cytochrome
oxidase activity ratios. The MAO activity found at
lower density could be associated with the mito-
chondria of the adrenergic nerve endings . These
would then represent a special kind of mitochon-
drion biochemically distinguishable from free brain
mitochondria. There is indeed evidence in the liter-
ature suggesting that intraterminal mitochondria
strongly differ in their enzymatic compcsition from
perikarial mitochondria (34, 35) . Finally, there
remains the possibility that in adrenergic nerve
endings, MAO may be partially localized in struc-
tures other than mitochondria; for instance, asso-
ciated with the nerve ending membranes or storage
vesicles. Evidence for a nonmitochondrial localiza-
tion of MAO has been provided for rat heart, sali-
vary gland, and vas deferens (36), as well as for
bovine splenic nerve (37).
Preliminary studies on substrate specificity and
susceptibility to inhibitors have disclosed kinetic
differences between the MAO of the mitochondrial
zone and that of the adrenergic ending zone (U .
Bretz, unpublished observations) . This suggests
that multiple molecular forms of MAO which have
been described in brain by others (38, 39) may be
present in different proportions in these two par-
ticle populations.
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